Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QuinFol LM
- Development stage
- Unknown
- Lead developer
- Zealina Life Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
QuinFol LM is a multi-nutrient dietary supplement developed and marketed by Zealina Life Sciences. It is formulated as a combination of several active ingredients, including L-methylfolate (1 mg), docosahexaenoic acid (DHA) (200 mg), methylcobalamin (1500 mcg), pyridoxal-5-phosphate (0.5 mg), and cholecalciferol (Vitamin D3) (2000 IU). The supplement is designed to support the production of red blood cells, maintain brain and nerve function, and promote overall metabolic health. L-methylfolate and methylcobalamin are the active forms of folate and vitamin B12, respectively, which are essential for DNA synthesis and homocysteine regulation. DHA is an omega-3 fatty acid critical for neurological development, while pyridoxal-5-phosphate (active Vitamin B6) and Vitamin D3 support immune and bone health. QuinFol LM is available in tablet and capsule formulations and is marketed as an approved product in India.
- Brand names
- QuinFol LM
02
Targets
MTR (Methionine synthase)FOLR1 (FRα)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on QuinFol LM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QuinFol LM.